Book a demo

Chemical intelligence powered by cypris.ai

Novox

2-(6-chloro-9H-carbazol-2-yl)propanoic acid · also: Rovera, Imadyl, Ridamyl, Quellin, OstiFen, Rimadyl

FormulaC15H12ClNO2
Mol. weight273.716
PubChem CID2581
InChIKeyPUXBGTOOZJQSKH-UHFFFAOYSA-N
SMILESCC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O
22,866Patents
536Research papers
2,013Patents - last 3 years
17Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Ionis Pharmaceuticals Inc1,105
2Procter and Gamble Co510
3Purdue Pharma LP497
4Syngenta Participations AG368
5Boehringer Ingelheim International GmbH290
6Merck Sharp & Dohme LLC276
7Bayer Pharma AG263
8Boehringer Ingelheim Animal Health USA Inc251
9Abbott Cardiovascular Systems Inc243
10Kenvue Brands LLC242

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61PTherapeutic activity (drug indications)16,598
2A61KMedicinal preparations16,406
3C07DHeterocyclic compounds7,084
4C12NMicroorganisms, enzymes3,389
5C07KPeptides3,208
6C07CAcyclic and carbocyclic compounds1,563
7A61LSterilising / disinfecting materials1,337
8Y02AClimate change adaptation1,275
9A61QCosmetics, personal care1,212
10G01NInvestigating / analysing materials1,144

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Inflammatory mediators and NSAID effects11
2Veterinary Pharmacology and Anesthesia4
3Animal Behavior and Welfare Studies1
4Animal Nutrition and Physiology1
5Bone health and treatments1
6Cancer, Stress, Anesthesia, and Immune Response1
7Helicobacter pylori-related gastroenterology studies1
8Microfluidic and Capillary Electrophoresis Applications1
9Osteoarthritis Treatment and Mechanisms1
10Pharmacogenetics and Drug Metabolism1

Technology trend analysis

Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.

See Cypris in action

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1A. E. Waterman‐PearsonUniversity of Bristol9
2J. V. RoughanNewcastle University7
3P. LeesRoyal Veterinary College7
4A. NolanUniversity of Glasgow6
5B. LudwigRoche (Switzerland)6
6Anton SimeonovNational Center for Advancing Translational Sciences5
7Ajit JadhavNational Center for Advancing Translational Sciences4
8B. Duncan X. LascellesUniversity of Bristol4
9Caroline LeeCommonwealth Scientific and Industrial Research Organisation4
10Dorothy Cimino BrownUniversity of Pennsylvania4

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the chemical structure and molecular formula of Novox?

Novox has the canonical chemical name 2-(6-chloro-9H-carbazol-2-yl)propanoic acid with the molecular formula C15H12ClNO2 and a molecular weight of 273.716 g/mol. Its InChI key is PUXBGTOOZJQSKH-UHFFFAOYSA-N.

What are the known commercial brand names for this compound?

Novox is marketed under numerous brand names including Rimadyl, Rovera, Imadyl, Quellin, OstiFen, Levafen, Norocarp, Carprieve, Vetprofen, Belprofen, Carprodyl, Carpaquin, Carprovet, Carofenvet, and Carprofene, among others.

Which companies hold the most patents related to this compound?

The leading patent holders are Ionis Pharmaceuticals Inc with 1105 patents, Procter and Gamble Co with 510 patents, Purdue Pharma LP with 497 patents, Syngenta Participations AG with 368 patents, and Boehringer Ingelheim International GmbH with 290 patents.

What research topics dominate the scientific literature on this compound?

The primary research focus is Inflammatory mediators and NSAID effects, which accounts for 10 papers. Other significant topics include Veterinary Pharmacology and Anesthesia with 3 papers, followed by single-paper topics covering Animal Behavior and Welfare Studies, Animal Nutrition and Physiology, Bone health and treatments, Osteoarthritis Treatment and Mechanisms, and Pharmacogenetics and Drug Metabolism.

Who are the most prolific researchers publishing on this compound?

A. E. Waterman‐Pearson from University of Bristol leads with 9 papers, followed by J. V. Roughan from Newcastle University and P. Lees from Royal Veterinary College, each with 7 papers. A. Nolan from University of Glasgow and B. Ludwig from Roche (Switzerland) each have 6 papers on the compound.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial